Used to treat severely low blood sugar, glucagon can be a lifesaving medication for people with diabetes. Here’s how it works and when and how to use it.

Chase Knickerbocker, Craig-Hallum: Sought clarity on U.S. core adjustments and SCIg market growth. Tharby confirmed "about 14%" U.S. growth and noted SCIg market growth in the "8% to 9% range overall.

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered ...

Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...

Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose ...

According to Towards Packaging consultants, the global packaging for aseptic manufacturing market is expected to witness ...

Request To Download Free Sample of This Strategic Report @ Disposable syringes are medical devices which are employed in one time administration of therapeutic agents to the body of a patient.

Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-yearPurified Cortrophin® Gel net revenues of ...

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the MHRA for all four formulations of ...

New findings explore the adalimumab biosimilar landscape, focusing on formulation, devices, and patient support programs that ...

Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...